SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001720725-22-000028
Filing Date
2022-02-24
Accepted
2022-02-24 16:15:12
Documents
87
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K oyst-20211231.htm   iXBRL 10-K 2045307
2 EX-10.17 oyster10-kxex1017xformofpsu.htm EX-10.17 80244
3 EX-23.1 q4-21ex231.htm EX-23.1 2095
4 EX-31.1 q4-21ex311.htm EX-31.1 12746
5 EX-31.2 q4-21ex312.htm EX-31.2 12444
6 EX-32.1 q4-21ex321.htm EX-32.1 7449
7 EX-32.2 q4-21ex322.htm EX-32.2 7444
13 oyst-20211231_g1.jpg GRAPHIC 150953
14 oyst-20211231_g2.jpg GRAPHIC 176205
  Complete submission text file 0001720725-22-000028.txt   9921374

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oyst-20211231.xsd EX-101.SCH 65550
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT oyst-20211231_cal.xml EX-101.CAL 103862
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT oyst-20211231_def.xml EX-101.DEF 276003
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oyst-20211231_lab.xml EX-101.LAB 800212
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oyst-20211231_pre.xml EX-101.PRE 520779
81 EXTRACTED XBRL INSTANCE DOCUMENT oyst-20211231_htm.xml XML 1364147
Mailing Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Filer) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39112 | Film No.: 22671119
SIC: 2836 Biological Products, (No Diagnostic Substances)